Correlates of Human Cytomegalovirus Cervical Shedding in Seropositive Women: Implications for Vaccine Development
The Journal of Infectious Diseases · 16.11.2026 · 234 (5) · e1095-e1103
DOI: 10.1093/infdis/jiag317 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 23.06.2026. Verfasst von Jinting Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Key Laboratory of Public Health Safety and Emergency, Prevention and Control Technology of Higher Education Institutions …. Hauptthemen laut MEDLINE: Virus Shedding, Cytomegalovirus, Cytomegalovirus Infections, Cervix Uteri. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Congenital human cytomegalovirus (HCMV) infection, caused by maternal transmission, is a leading cause of congenital disabilities and poses a substantial global disease burden. Accumulating evidence indicates that the majority of HCMV infections in newborns stem from nonprimary infections. But the relationship between viral shedding and host immune status in seropositive individuals remains poorly elucidated.
Methods
A total of 142 HCMV-seropositive women of reproductive age were enrolled from Taizhou, China. Serum samples and cervical secretions were collected, and antibody levels and HCMV DNA loads were detected, respectively.
Results
Serum IgG binding to postfusion glycoprotein B (gB), cell-surface-expressed gB, and pentameric complex (PC) was significantly associated with HCMV shedding in cervical secretions. In contrast, no significant associations were observed between cervical shedding and serum IgG binding to prefusion gB or the structural antigen pp150 nor with neutralizing antibody (NAb) titers against Towne and ADR131 strains in MRC-5 cells or ADR131 strain in ARPE-19 cells.
Conclusions
These findings advance the current understanding of the interplay between viral shedding and humoral immunity in HCMV-seropositive individuals. Importantly, they provide novel evidence supporting site-specific HCMV shedding as a potential biomarker for reinfection/reactivation, and a potential exploratory surrogate marker for subsequent vaccine endpoint validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Key Laboratory of Public Health Safety and Emergency, Prevention and Control Technology of Higher Education Institutions in Jiangsu Province, Center for Global Health, School of Public Health…
- National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, China.
- Taizhou Laboratory, Jiangsu Recbio Technology Co., Ltd, Taizhou, China.
- Department of Reproductive Medicine, Taizhou People's Hospital, Taizhou, China.
ORCID-Profile: Jinting Li, Jianming Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Liu, M., Li, J., Zhou, Y., Xu, Y., Zhu, D., Liu, Y., & Wang, J. (2026). Correlates of Human Cytomegalovirus Cervical Shedding in Seropositive Women: Implications for Vaccine Development. The Journal of Infectious Diseases, 234(5), e1095-e1103. https://doi.org/10.1093/infdis/jiag317
Vancouver
Li J, Liu M, Li J, Zhou Y, Xu Y, Zhu D, et al. Correlates of Human Cytomegalovirus Cervical Shedding in Seropositive Women: Implications for Vaccine Development. The Journal of Infectious Diseases. 2026;234(5):e1095-e1103. doi:10.1093/infdis/jiag317
BibTeX
@article{Li2026,
author = {Li, Jinting and Liu, Meiyao and Li, Jiao and Zhou, Yingying and Xu, Yanbing and Zhu, Dandan and Liu, Yong and Wang, Jianming},
title = {Correlates of Human Cytomegalovirus Cervical Shedding in Seropositive Women: Implications for Vaccine Development},
journal = {The Journal of Infectious Diseases},
year = {2026},
volume = {234},
number = {5},
pages = {e1095--e1103},
doi = {10.1093/infdis/jiag317}
}
EUVIMED